AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.
Financial Post ·
News Provided by Wall Street Investor on behalf of MindWalk Holdings Corp. AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) — Wall Street Investor News Commentary – Antibodies have become one of medicine’s most valuable drug classes, with 144 FDA-approved antibody drugs on the market as of August 2025 and global sales of more than $267 […]
News Provided by Wall Street Investor on behalf of MindWalk Holdings Corp. Read More